Vice-President Business Development
Bill has over 20 years of business experience in a wide variety of biotechnology fields, including vaccines, human genetics, drug development, manufacturing and extensive interactions with the pharmaceutical industry. Over the past 15 years, Bill has been involved in business development in the biotechnology sector with both private and publicly traded companies. He has executed numerous technology deals with Pharma, academic institutions and hospitals as well as securing financing ($150M+) for various companies with many venture firms. Bill currently serves on the Board of Directors of a publicly traded company on the TSX. He has a PhD in Genetics.